The Effect of Environmental Pollution on the Prognosis of Gastric Cancer
NCT ID: NCT06686966
Last Updated: 2024-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3400 participants
OBSERVATIONAL
2010-01-01
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
NCT06854146
Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.
NCT06641700
PWP1's Expression in Gastric Cancer.
NCT06392750
The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer
NCT06977386
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
NCT06078930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
gastric cancer
be diagnosed as gastric cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients diagnosed with gastric cancer by pathological biopsy before surgery;
* patients without chemotherapy, radiotherapy, targeted and immunotherapy before enrolment;
* willing to participate in this study and sign the informed consent;
* complete clinical data.
Exclusion Criteria
* patients with systemic diseases such as severe cardiopulmonary insufficiency that affect the choice of treatment plan;
* patients who are not suitable for enrolment as assessed by the investigator;
* incomplete clinical data.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Peng
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZZ2024-292-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.